You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

List of Excipients in API gemifloxacin mesylate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing gemifloxacin mesylate

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Merus Labs International Inc	FACTIVE	gemifloxacin mesylate	44001-321	CELLULOSE, MICROCRYSTALLINE
Merus Labs International Inc	FACTIVE	gemifloxacin mesylate	44001-321	CROSPOVIDONE
Merus Labs International Inc	FACTIVE	gemifloxacin mesylate	44001-321	HYPROMELLOSE 2910
Merus Labs International Inc	FACTIVE	gemifloxacin mesylate	44001-321	MAGNESIUM STEARATE
Merus Labs International Inc	FACTIVE	gemifloxacin mesylate	44001-321	POLYETHYLENE GLYCOL 4000
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for gemifloxacin mesylate

Excipient focus: CELLULOSE, MICROCRYSTALLINE

gemifloxacin mesylate drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merus Labs International Inc	gemifloxacin mesylate	44001-321
Vansen Pharma Inc	gemifloxacin mesylate	44004-321
>Company	>Ingredient	>NDC

gemifloxacin mesylate drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSPOVIDONE

gemifloxacin mesylate drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merus Labs International Inc	gemifloxacin mesylate	44001-321
Vansen Pharma Inc	gemifloxacin mesylate	44004-321
>Company	>Ingredient	>NDC

gemifloxacin mesylate drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE 2910

gemifloxacin mesylate drug variants containing HYPROMELLOSE 2910

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merus Labs International Inc	gemifloxacin mesylate	44001-321
Vansen Pharma Inc	gemifloxacin mesylate	44004-321
>Company	>Ingredient	>NDC

gemifloxacin mesylate drug variants not containing HYPROMELLOSE 2910

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

gemifloxacin mesylate drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merus Labs International Inc	gemifloxacin mesylate	44001-321
Vansen Pharma Inc	gemifloxacin mesylate	44004-321
>Company	>Ingredient	>NDC

gemifloxacin mesylate drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 4000

gemifloxacin mesylate drug variants containing POLYETHYLENE GLYCOL 4000

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merus Labs International Inc	gemifloxacin mesylate	44001-321
Vansen Pharma Inc	gemifloxacin mesylate	44004-321
>Company	>Ingredient	>NDC

gemifloxacin mesylate drug variants not containing POLYETHYLENE GLYCOL 4000

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 6000

gemifloxacin mesylate drug variants containing POLYETHYLENE GLYCOL 6000

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merus Labs International Inc	gemifloxacin mesylate	44001-321
Vansen Pharma Inc	gemifloxacin mesylate	44004-321
>Company	>Ingredient	>NDC

gemifloxacin mesylate drug variants not containing POLYETHYLENE GLYCOL 6000

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE

gemifloxacin mesylate drug variants containing POVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merus Labs International Inc	gemifloxacin mesylate	44001-321
Vansen Pharma Inc	gemifloxacin mesylate	44004-321
>Company	>Ingredient	>NDC

gemifloxacin mesylate drug variants not containing POVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

gemifloxacin mesylate drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Merus Labs International Inc	gemifloxacin mesylate	44001-321
Vansen Pharma Inc	gemifloxacin mesylate	44004-321
>Company	>Ingredient	>NDC

gemifloxacin mesylate drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.